News and reflections from the world of AI

Aiforia Raises €12.6M in Series B Funding to Enhance Precision Diagnostics and Preclinical Analysis in Pathology

Helsinki – June 3, 2021 - Aiforia, a software company providing AI-based solutions for clinical and preclinical image analysis in pathology, announced today the closing of the first €12.6M tranche of their Series B round. The funding round has the potential to reach €25.2M if investors exercise the optional second tranche. The funding round is led by Epredia's UK entity, a subsidiary of PHC ...

Automating the detection of malaria parasites in blood smear

Introduction Malaria is a life-threatening disease caused by Plasmodium parasites and transmitted through the bites of infected female Anopheles mosquitoes. There are five parasite species that cause malaria in humans of which P. falciparum and P. vivax pose the greatest threat, often progressing to severe illness, multi-organ failure, or death.

Interview with veterinary pathologist on AI-assisted screening of bone marrow cellularity changes

Bone marrow cellularity is the volume ratio of hematopoiesis (the body’s manufacturing of blood cells) and fat, and decreases with age. Many compounds can alter the cellularity of bone marrow making it a vital tissue for analysis by pathologists in pharmacologic safety studies. Quantitative data is vital for statistical evaluation in risk and toxicity assessments.

Aiforia and X-ZELL partner to scale up novel AI-powered method for early cancer detection

Singapore, Helsinki -- Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical image analysis, and X-ZELL, a clinical stage med-tech company aiming to make early, affordable cancer detection accessible to everyone, have entered into a strategic partnership to integrate X-ZELL’s novel rare cell detection technology with Aiforia’s deep learning AI software.

Entrevista con el Dr. Jose Lanciego

English Director Científico del Laboratorio de Neuroanatomía del Centro de Investigación Médica Aplicada de la Universidad de Navarra, Pamplona, España.

Interview with Dr. Jose Lanciego

Español Staff Scientist and Director, Laboratory of Functional Basal Ganglia Neuroanatomy Center for Applied Medical Research at the University of Navarra, Pamplona, Spain